Earnings call transcript: Appear’s Q2 2026 revenue falls 30% as stock edges higher

Appear reported Q2 2026 revenue of NOK 189.6m (-30% YoY) and net profit of NOK 21m (-67% YoY), with gross margin holding at 70% but free cash flow deteriorating to -NOK 54.3m and cash falling to NOK 78m. Management reaffirmed full-year revenue guidance of NOK 880m–920m (10%–15% growth), attributing weakness mainly to EMEA procurement timing and a shift toward channel coverage, while support/recurring revenue is building. Shares rose 1.32% to $45.90 pre-market despite a volatile prior period, supported by a valuation signal (P/E 20.5, PEG 0.18) that implies the market may be underpricing growth recovery.

Analysis

The key read-through is not the headline revenue slump; it is that the business is still tethered to lumpy procurement calendars while management is trying to re-rate it on recurring revenue and software optionality. That creates a classic transition risk: the gross margin profile looks stable, but the sales engine is becoming less predictable before the recurring mix is large enough to smooth cash generation. In other words, the market is being asked to underwrite a software-like multiple on a hardware-like working-capital profile.

Winners here are channel partners, systems integrators, and any competitor with a stronger indirect-sales footprint in EMEA/APAC, because the company is effectively outsourcing market access to fix its geographic gap. The likely second-order loser is internal sales productivity: as the mix shifts away from direct Tier-1 relationships, near-term revenue per seller may compress before the partner network scales. That also favors peers with steadier backlog conversion and less inventory intensity; the market will eventually discount cash conversion more than reported margin.

The near-term risk is balance-sheet optics rather than solvency: free cash flow is negative, cash is shrinking, and inventory is absorbing capital just as revenue becomes more volatile. The 1-3 month catalyst is the Q3 order book and the Oct. 29 Capital Markets Day; if management cannot show a sharper conversion path, the reaffirmed full-year guide will start to look like a bridge to a later reset. Over 6-18 months, the thesis only works if support/software rises enough to reduce lumpiness and if channel economics do not dilute deal quality.

Contrarian view: the market may be over-fixated on the cheap P/E/PEG screen and underpricing the fact that earnings quality is deteriorating faster than the model is being diversified. I would not chase the bounce; I would rather wait for proof that bookings and cash flow inflect before paying up for the growth story.

Key Decisions for Investors

• Stay flat / do not add on the post-earnings bounce; require evidence of H2 order acceleration and cash stabilization before taking long exposure.
• If the shares rally into the Oct. 29 Capital Markets Day without a bookings inflection, fade strength with a short or put-spread expression; thesis is invalidated by a visible pickup in order intake and free-cash-flow improvement.
• Rotate exposure toward the better second-order beneficiaries: channel partners, systems integrators, and software-heavy live-production peers with less inventory drag and more recurring revenue.
• Set a 1-3 month alert on cash balance and working-capital intensity; if cash trends toward a sub-NOK 60m cushion or inventory keeps rising, reassess for dilution risk.